US/UK/Canada

Share

Contacts

  • Rikard Akhtarzand

    CEO


    Grev Turegatan 3, floor 4, SE 114 46 Stockholm, Sweden
    08 128 766 00
    http://www.addvisegroup.com
    • Pick a time period -

    The nomination committee’s proposal of board of directors in ADDvise Group AB (publ) - Regulatory information

    To the annual general Meeting (AGM) of ADDvise Group AB (publ) on 23 April 2021, the nomination committee has decided to propose the re-election of the current board members Rikard Akhtarzand, Fredrik Celsing, Staffan Torstensson and Erland Pontusson as members of the board of directors. In addition, the nomination committee proposes the election of Johanne Louise Brændgaard. It is proposed that Staffan Torstensson is re-elected chairman of the board of directors. Johanne Louise Brændgaard has a master’s degree in international business economics from Aalborg University, Denmark. Johanne

    ADDvise Group acquires MRC Systems FZE - Regulatory information

    ADDvise Group AB (publ) ("ADDvise") has entered into a share purchase agreement with the shareholders of MRC Systems FZE (the "Company" and "MRC") regarding an acquisition of 100 percent of the shares in the Company (the "Acquisition"). MRC develops and manufactures cleanrooms for the pharmaceutical industry and hospitals. The Company has its headquarters and production facility located in Dubai. The Company currently employs around 110 people. The initial purchase price amounts to USD 5 million. In addition to the initial purchase price, additional earn-outs of maximum USD 3 million

    ADDvise Group AB receives SEK 27.8 million through the warrants of series 2019/2021 – Regulatory information

    Holders of warrants of series 2019/2021 subscribed for 42,787,137 warrants, corresponding to 99.41 percent of the outstanding warrants, for subscription of 42,787,137 shares of series B at the subscribtion price of SEK 0.65. Through the exercise of the warrants, ADDvise receives SEK 27,811,639 before issue costs. Background During the first quarter of 2019, ADDvise carried out a rights issue of units, consisting of one (1) newly issued series B share and one (1) warrant of series 2019/2021. Each warrant of series 2019/2021 entitled the holder to subscribe for one (1) new B share in

    Last day of trading in warrants of series 2019/2021 is February 4, 2021 - Regulatory information

    February 4, 2021 is the last day of trading in warrants of series 2019/2021. The subscription period for warrants of series 2019/2021 runs until and including February 8, 2021. Each warrant gives the right to subscribe for one (1) new B share in ADDvise. The subscription price for the warrants is SEK 0.65 per share of series B. Summarized terms for the warrants of series 2019/2021Subscription period: January 25, 2021 – February 8, 2021 Size of issue: 43,042,288 warrants of series 2019/2021. Upon full exercise, 43,042,288 shares will be issued and ADDvise receives approximately SEK

    Result update Q4, full year 2020 and the board of directors’ dividend proposal - Regulatory information

    Preliminary numbers indicate very strong growth for ADDvise Group during the fourth quarter for 2020, which will be substantially better than last year. ADDvise Group considers this to be above market expectations. With a more normalized market, an increase of ADDvise’s own products and margins, and a continued control of costs; EBITDA has increased as a result in the fourth quarter 2020. The net sales and EBITDA result 2020 will be ADDvise Group’s strongest so far. · The EBITDA result of the fourth quarter 2020 is estimated to approximately SEK 15.9 million (9.6), corresponding to an

    The subscription period for warrants of series 2019/2021 begins today - Regulatory information

    Today, on 25 January 2021, the subscription period begins for the warrants of series 2019/2021 that were issued in connection with ADDvise Group AB (publ)'s (“ADDvise” or the “Company”) issue of units in 2019. The subscription period is between January 25 and February 8, 2021. Each warrant of series 2019/2021 entitles to subscribe for one (1) new share of series B in ADDvise at a price of SEK 0.65 per share of series B. If all warrants of series 2019/2021 are exercised, the Company will receive approximately SEK 28 million before issue costs. In order for the warrants not to expire without

    Certain Board members, senior executives and major shareholders have undertaken to subscribe for shares for a total of approx. SEK 15.5 million by exercising warrants of series 2019/2021

    The following board members, senior executives and major shareholders in ADDvise Group AB (publ) (“ADDvise”) have irrevocably undertaken to exercise a total of 23,813,195 warrants of series 2019/2021, which corresponds to a total of approximately 55% of the warrants of series 2019 / 2021 (“The Warrants”). The subscription means that ADDvise will receive issue proceeds of at least SEK 15.5 million. The subscription period for the Warrants runs from and including January 25, 2021 until and including February 8, 2021. Holders of Warrants have the right to subscribe for one (1) new share of

    ADDvise Group decides to end the arranged fixed income investor calls - Regulatory information

    In the press release dated 18 November 2020 ADDvise Group AB announced that the company had mandated Pareto Securities AB to arrange fixed income investor calls regarding a senior secured bond issue. Based on the continuing strong results and increasingly positive cash flow in the group, and that the contemplated bond issue would result in unfavorable terms and conditions for the company, ADDvise Group AB has decided to end the arranged fixed income investor calls. However, the company will continue to evaluate the potential for a future secured bond issue under the condition that it can

    ADDvise Group to arrange fixed income investor calls - Regulatory information

    ADDvise Group AB (publ) (“ADDvise” or the “Company”) has mandated Pareto Securities AB to arrange fixed income investor calls commencing on 20 November 2020. Subject to, inter alia, market conditions, a SEK-denominated senior secured bond issue in an initial amount of MSEK 250 with a tenor of 3 years may follow. The net proceeds from the contemplated bond issue will be utilised to refinance the Company’s outstanding bonds and other debt facilities, finance the previously announced acquisition of MRC Systems Ltd, and for general corporate purposes. In conjunction with the contemplated

    ADDvise Group is updating financial target relating to EBITDA margin - Regulatory information

    The board of directors in ADDvise Group has today, based on the strong result in the company, adopted a new EBITDA margin target. ADDvise’s previous EBITDA margin target was set at 10%. The new target is set at an EBITDA margin of 15%. In September 2017, when ADDvise adopted the previous EBITDA target of 10%, the EBITDA margin in the group as per Q3 2017, year to date, was at a level of 6.1%. As per Q3 2020, year to date, the EBITDA margin was at a level of 11.4%. - We have been working hard to improve the profitability in the group both by optimizing cost and by focusing on the

    ADDvise signs Letter of Intent to acquire MRC Systems Ltd - Regulatory information

    ADDvise Group AB (publ) (”ADDvise”) has signed a Letter of Intent with the shareholders of MRC Systems Ltd (the ”Company” and ”MRC”) regarding an acquisition of 100 percent of the shares in MRC (the ”Acquisition”). MRC develops and manufactures cleanrooms for the pharmaceutical industry and hospitals. The Company has its headquarters and production facility located in Dubai. The Company owns an additional production facility in Spain. The Company’s revenue is expected to amount to approximately USD 9.80 million with an adjusted EBITDA of approximately USD 1.10 million for the financial

    Hanna Myhrman is appointed to General Legal Counsel and to an executive member of the group management - Regulatory information

    On 1 November 2020 Hanna Myhrman commences as General Legal Counsel and as an executive member of the ADDvise Group AB (publ) group management team. Hanna Myhrman, born 1992, has a Master of Laws from the University of Lund. Hanna Myhrman has been working as Legal Counsel in ADDvise Group during the past year. Before joining ADDvise Group Hanna Myhrman worked for a global law firm mainly with M&A, financing, and corporate law. - We are now broadening the competence in the management team in order to accelerate ADDvise’s growth journey. Hanna will be an important resource in this work,

    ADDvise Group’s nomination committee for the Annual General Meeting 2021

    In accordance with the resolution at the 2020 annual general meeting of ADDvise Group AB the nomination committee for the annual general meeting 2021 shallbe composed of representatives of the three largest shareholders by votes listed in the shareholders’ register maintained by Euroclear Sweden as of30 June 2020 and the chairman of the board of directors acting as rapporteur. The representative appointed by the largest shareholder by votes shall beappointed chairman of the nomination committee. The nomination committee has now been appointed and consist of the following members:

    ADDvise Group’s reporting dates 2021

    Year-end report 2020 (Jan-Dec)                                     2021-02-25 Last day for shareholders to request                              2021-03-05an item to be included to the agendaof the Annual General Meeting Annual General Meeting                                                 2021-04-23 Three-month report (Jan-March)                                    2021-04-23 Six-month report (Jan-Jun)                                             2021-07-23 Nine-month report (Jan-Sep)                                          2021-10-27 Year-end report 2021 (Jan-Dec)

    ADDvise receives allocation decision worth approximately MSEK 8 – Regulatory information

    ADDvise Group AB (publ)’s subsidiary Sonar Oy has received an allocation decision from Jyväskylä Hospital NEO in Finland worth approximately MSEK 8. The allocation decision consists of orders during three years regarding ultrasound systems for use in healthcare.   In accordance with Finnish procurement law can the allocation decision be appealed directly to the procuring unit, which two participants have decided to do.  For further information, please contact:Rikard Akhtarzand, CEO+46 765-25 90 71rikard.akhtarzand@addvisegroup.se   Important information: This

    ADDvise Group AB (publ) purchases its own bond - Regulatory information

    ADDvise Group AB (publ) has today purchased bonds in ADDvise Group AB (publ) (ISIN SE0010298166) on the market to the nominal amount of SEK 450 000. The average price of the purchase was SEK 84.72. The purchase is motivated by the strong financial development in ADDvise Group AB. The purpose with the purchase is to optimize the capital structure in the group. After the purchase, the nominal amount of ADDvise Group AB’s holding of its own bond correspondences to SEK 450 000.  For further information, please contact:Rikard Akhtarzand, CEO+46 765-25 90 71rikard.akhtarzand@

    Stronger result than anticipated for ADDvise Group during the second quarter 2020 - Regulatory information

    The preliminary result for ADDvise Group during the second quarter 2020 will be substantially better than what ADDvise Group considers the market to expect and in comparison with last year. The net sales for the second quarter are expected to be approximately 101 MSEK (92.5), corresponding to an organic increase of approximately 10 % compared to the same period last year. EBITDA for the period is expected to approximately 15 MSEK (7.2). The EBT, earnings before tax, for the second quarter is expected to approximately 9 SMEK (-0.2).   A strong order intake at the beginning of the year, of

    ADDvise receives order worth approximately MSEK 6 - Regulatory information

    ADDvise Group AB (publ) subsidiary Hettich Labinstrument Aktiebolag has received an order from the Swedish Defence Materiel Administration on behalf of the National Board of Health and Welfare worth approximately MSEK 6 regarding medical swabs. The medical swabs will, among other things, be used for sample-taking of patients tested for suspected COVID-19 infection. Delivery is planned to take place during the second quarter 2020.  For further information, please contact: Rikard Akhtarzand, CEO+46 765-25 90 71rikard.akhtarzand@addvisegroup.se Important information:This

    ADDvise receives order worth approximately MSEK 6 - Regulatory information

    ADDvise Group AB (publ) subsidiary Hettich Labinstrument Aktiebolag has received an order from Region Skåne worth approximately MSEK 6 regarding medical swabs. The medical swabs will, among other things, be used for sample-taking of patients tested for suspected COVID-19 infection. Delivery is planned to take place during the second quarter 2020. -    We see a massive increase of requests of our products related to COVID-19. Currently most of the requests concerns different types of protective devices and equipment used for testing of COVID-19. In addition, in the beginning of the second

    The order intake for ADDvise Group during Q1 2020 amounted to MSEK 137.3 corresponding to an increase of 63 % - Regulatory information

    ADDvise Group’s total order intake during the first quarter 2020 amounted to MSEK 137.3 corresponding to an increase of 63 per cent compared with the same period last year. The order intake for the same period last year amounted to MSEK 84.4. 37 per cent of the increase in order intake is due to organic growth. In addition, it is a significant increase compared to the preliminary order intake that was published through the press release dated 24 March 2020. The strong order intake is partly due to the intensified use of medical equipment and consumables due to the outbreak of COVID-19.

    The nomination committee’s proposal of board of directors in ADDvise Group AB (publ) - Regulatory information

    The nomination committee of ADDvise Group AB (publ) has decided to propose the reelection of the current board members Rikard Akhtarzand and Fredrik Celsing as members of the board of directors at the annual general Meeting (AGM) 2020. In addition, the nomination committee proposes election of Staffan Torstensson and Erland Pontusson. Furthermore, it is proposed that Staffan Torstensson is elected chairman of the board of directors. The current chairman of the board of directors, Meg Tivéus, has declined re-election. Staffan Torstensson has a Master of Science in Business Administration,

    COO in ADDvise Group AB, Erland Pontusson, retires but remains in the group as Senior Advisor - Regulatory information

    Erland Pontusson, COO and member of the management team in ADDvise Group AB, will be retiring on 30 June 2020 in connection with his 67[th] birthday. Erland Pontusson will thereafter remain in the group as “Senior Advisor”. In addition, Erland Pontusson has also been proposed, by the nomination committee of the annual general meeting 2020, to be elected as a new member of the board of directors of ADDvise Group AB.   After 30 June 2020, the work performed by Erland Pontusson as the COO will initially be taken over by existing positions within ADDvise Group AB.   Erland Pontusson

    ADDvise signs a new agreement with Laborie with a total order value of at least MSEK 50 - Regulatory information

    ADDvise Group AB (publ)’s subsidiary Sonesta Medical AB signs a new agreement with Laborie Medical Technologies (“Laborie) granting Laborie the right to sell Sonesta Medical’s urology- and gynecology chairs and video fluoroscopy tables (the “Products”) in all countries in the world with an exclusive right to distribution in USA and France, United Kingdom, Ireland, Germany, Belgium, Netherlands, Austria, Switzerland and Luxembourg (the “Exclusive Markets”). The initial term of the agreement is three years. The total value of the orders during the initial term of the agreement is at least

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe